跳至主要内容
临床试验/NL-OMON43194
NL-OMON43194撤回不适用

Arterial wall inflammation measured with 18F-FDG PET/CT in patients with familial hypercholesterolemia before and after treatment with a PCSK-9 inhibitor - FLASH

Academisch Medisch Centrum0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • patients with:
  • Aged 50 years or older
  • Familial hypercholesterolemia intermediate or severe genotype
  • Elevated LDL levels prior to start treatment
  • No previous cardiovascular events
  • No treatment with a PCSK9 inhibitor or willing to stop with the treatment for 6 weeks prior to baseline measurements

排除标准

  • 1. Malignant diseases or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator.
  • 2. Chronic or recent (<1 month) infections and/or clinical signs of acute infection and/or CRP>10
  • 3. Auto-immune diseases
  • 4. Recent or chronic immunosuppressant or antibiotic usage
  • 5. Type I or II diabetes mellitus
  • 6. Standard contra-indications to 18F-FDG PET/CT based on physicians experience and current practices;Control group:
  • * A history of cardiovascular disease
  • * A known elevated risk factor for cardiovascular disease
  • * Use of any cardiovascular medication, including but not limited to lipid-lowering therapy, antihypertensive drugs, antidiabetic drugs, platelet aggregation inhibitors and anticoagulants

研究者

相似试验